Skip to main content

Table 3 Comparison between the studied groups regarding IHC expression of prohibitin

From: Prohibitin: targeting peptide coupled to ovarian cancer, luteinization and TGF-β pathways

Parameters

Group

F (P)

Control

Benign

Borderline

Malignant

 

Intensity (Mean ± SD)

2.2 ± 0.6

2.0 ± 0.0

2.6 d ±0.5

3.0 d ±0.0

0.001*

% (Mean ± SD)

69.3 ± 10.2

66.3 ± 16.0

85.6 d ±9.0

96.3 d ±3.9

0.001*

Score (Mean ± SD)

147.8 ± 43.5

132.5 ± 31.9

226.7 d ±64.4

288.8 d ±11.8

0.001*

  1. F One Way ANOVA, d significantly different group (s), *P < 0.05 (significant)